Visomitin – eye drops against age-related eye pathologies – successfully completed several stages of clinical trials and was approved in Russia. Mitotech LLC , a Moscow State University based company, has developed manufacturing of SkQ substance and SkQ based drug and initiated distribution of Visomitin through Russian pharmacies. (Learn More)